FUSN - Fusion Pharmaceuticals Inc.
IEX Last Trade
21.555
21.555 100.000%
Share volume: 0
Last Updated: Mon 03 Jun 2024 08:15:20 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-08 | 2023-03-16 | 2023-05-11 | 2023-08-08 | 2023-11-07 | |
| Cash flow financing | 1.709 M | 9.988 M | 28.905 M | 131.000 K | 59.515 M | 24.308 M | 328.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -14.971 M | -17.316 M | -21.625 M | -19.364 M | -25.435 M | -19.584 M | -18.839 M | |
| Net income | -19.909 M | -19.073 M | -24.013 M | -24.617 M | -24.291 M | -25.175 M | -17.252 M | |
| Depreciation | 203.000 K | 216.000 K | 242.000 K | 248.000 K | 273.000 K | 337.000 K | 374.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 325.000 K | 177.000 K | 215.000 K | 61.000 K | 89.000 K | 62.000 K | 41.000 K | |
| Investing Cashflow | 19.131 M | 9.641 M | 37.248 M | -42.933 M | -24.528 M | -26.319 M | 13.326 M | |
| Net Borrowings | -197.034 M | -190.177 M | -174.796 M | -138.230 M | -170.051 M | -156.757 M | -150.127 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -595.000 K | -375.000 K | -222.000 K | -950.000 K | -1.223 M | -710.000 K | -473.000 K | |
| Cash Change | 196.812 M | 198.423 M | 205.481 M | 170.874 M | 209.844 M | 198.096 M | 191.348 M |